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Bi-allelic variants in HOPS complex subunit
VPS41 cause cerebellar ataxia and abnormal
membrane trafficking
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Membrane trafficking is a complex, essential process in eukaryotic cells responsible for protein transport and processing.
Deficiencies in vacuolar protein sorting (VPS) proteins, key regulators of trafficking, cause abnormal intracellular segregation of
macromolecules and organelles and are linked to human disease. VPS proteins function as part of complexes such as the homotypic
fusion and vacuole protein sorting (HOPS) tethering complex, composed of VPS11, VPS16, VPS18, VPS33A, VPS39 and VPS41.
The HOPS-specific subunit VPS41 has been reported to promote viability of dopaminergic neurons in Parkinson’s disease but to
date has not been linked to human disease. Here, we describe five unrelated families with nine affected individuals, all carrying
homozygous variants in VPS41 that we show impact protein function. All affected individuals presented with a progressive neuro-
developmental disorder consisting of cognitive impairment, cerebellar atrophy/hypoplasia, motor dysfunction with ataxia and dys-
tonia, and nystagmus. Zebrafish disease modelling supports the involvement of VPS41 dysfunction in the disorder, indicating lyso-
somal dysregulation throughout the brain and providing support for cerebellar and microglial abnormalities when vps41 was
mutated. This provides the first example of human disease linked to the HOPS-specific subunit VPS41 and suggests the importance
of HOPS complex activity for cerebellar function.
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Abbreviations: CRISPR = clustered regularly interspaced short palindromic repeats; ESC = embryonic stem cell; GFP = green
fluorescent protein; HOPS = homotypic fusion and vacuole protein sorting; LRO = lysosome-related organelle; VPS = vacuolar pro-
tein sorting
Introduction
Membrane trafficking in eukaryotic cells is critical for pro-
tein transport and processing of endocytic cargo for degrad-
ation. It is regulated by highly conserved vacuolar protein
sorting (VPS) proteins, which were first discovered through
genetic screening for yeast mutants exhibiting several classes
of distinct trafficking phenotypes (Conibear and Stevens,
1995; Bonangelino et al., 2002). Analogous phenotypes
have since been observed in mammalian cells (Huizing et al.,
2008) and trafficking defects and VPS protein deficiencies
have been linked to numerous human neurological diseases
(Supplementary Table 1). For example, a homozygous foun-
der mutation in VPS11 was found in eight affected individu-
als from four unrelated Ashkenazi Jewish families who
presented with hypomyelination, developmental delay, hypo-
tonia, microcephaly, and seizures (Zhang et al., 2016), while
VPS33A loss-of-function has been linked to psychomotor re-
tardation, delayed myelination, cerebral calcification, and
lysosomal dysfunction (Kondo et al., 2017). However,
whether other VPS proteins also have a role in disease
remains to be clarified.
VPS proteins frequently function within multi-subunit
tethering complexes, the best-documented being the hexame-
ric HOPS (homotypic fusion and vacuole protein sorting)
and CORVET (class C core vacuole/endosome tethering)
complexes. The HOPS complex is thought to regulate fusion
of lysosomes with endo- or autophagosomes and consists of
six VPS subunits: VPS39 and VPS41, which are HOPS-spe-
cific, as well as VPS11, VPS16, VPS18 and VPS33A, which
are also present in the CORVET complex (Bowers and
Stevens, 2005). VPS39 and VPS41 interact with RAB7 to
specifically target the HOPS complex to late endosomes
(Balderhaar and Ungermann, 2013).
Yeast strains with disrupted VPS41 function exhibit
deformities in vacuolar morphology and trans-Golgi traffick-
ing of vacuolar components that can be rescued upon com-
plementation with the wild-type gene (Radisky et al., 1997).
As lysosomes in higher eukaryotes are analogous organelles
to yeast vacuoles, abnormalities in lysosome-related organ-
elles (LROs)—including lysosomes, melanosomes and phag-
osomes, among others—are likely to occur in instances of
VPS41 deficiency, for example in vertebrate cells (Delevoye
et al., 2019). However, proof of this theory could not be
established to date because of early embryonic lethality of
the only currently described Vps41 mouse knockout model
preventing further analysis (Aoyama et al., 2012).
Here, we report five unrelated families with nine affected
individuals with homozygous missense variants in VPS41,
presenting with an autosomal recessive, progressive develop-
mental disorder consisting of cerebellar atrophy/hypoplasia,
cognitive impairment, motor dysfunction with ataxia and
dystonia, and abnormal membrane-bound vesicles, as
assessed by electron microscopy in lymphocytes and lympho-
blastoid cells.
Materials and methods
Detailed methodology is provided in the Supplementary
material.
Human subjects
All probands were investigated by their referring physicians.
Most genetic analyses were performed in a diagnostic setting.
Legal guardians of affected individuals gave informed consent
for genomic investigations and publication of anonymized data.
This study was approved by institutional review board of
KFSHRC (RAC# 2120022). Exome sequencing was performed
as previously described (AlMuhaizea et al., 2020; Perenthaler
et al., 2020).
In silico analyses
Functional pathway gene ontology enrichment analyses were
performed using Database for Annotation, Visualization and
Integrated Discovery (DAVID) (Dennis et al., 2003) and
Ingenuity Pathways Analysis (IPA) (QIAGEN Inc.). A right-
tailed Fisher’s exact test was used to calculate a P-value deter-
mining the probability that the biological function (or pathway)
assigned to that dataset is explained by chance alone. Gene
interaction network analysis was performed using IPA. Genes
were mapped to their corresponding gene objects in the
IngenuityV
R
Knowledge Base. SwissModel, RaptorX and
iTASSER were used to produce homology models. Models were
manually inspected and mutations evaluated using PyMOL.
Human embryonic stem cell
experiments
VPS41 knockout embryonic stem cells (ESCs) were generated by
clustered regularly interspaced short palindromic repeats
(CRISPR)-Cas9 mutagenesis, as previously described (Barakat
et al., 2018; Perenthaler et al., 2020). ESCs were used in rescue
experiments in which wild-type or mutant VPS41 was expressed
transiently. Full experimental details are provided in the
Supplementary material.
CRISPR/Cas9 zebrafish mutagenesis
CRISPR/Cas9 mutagenesis was performed largely as previously
described using guide RNA (gRNA) targeting exon 4 of vps41.
Cas9 nuclease was synthesized (Kuil et al., 2019) and co-
injected with gRNAs into fertilized zebrafish oocytes. Indel effi-
ciency and frequency were determined using Sanger sequencing.
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LysoTrackerTM staining
For LysoTrackerTM staining, carried out as previously described
(Kuil et al., 2019), zebrafish larvae were incubated in the dark
at 2C for 40 min in 1.5 ml tubes with 100 ll LysoTrackerTM
Red DND-99 (ThermoFisher) diluted to a final concentration of
10 lM in E3 media containing 200 lM PTU. Medium was
replaced with fresh E3-PTU and incubated 20 min before
imaging.
In vivo imaging and image analysis
Larvae were anaesthetized using tricaine (0.016%) prior to
being mounted in 1.8% low melting point agarose (Kuil et al.,
2019). In vivo fluorescence imaging used a Leica SP5 intravital
confocal microscope with a 20 water-dipping objective (Leica
Plan-Apochromat, NA = 1.0). Images were analysed using
ImageJ software (Schindelin et al., 2012).
Optokinetic response assay
Zebrafish embryos [5 days post-fertilization (dpf)] were posi-
tioned in 6% methylcellulose/1 E3 within clear plastic wells
and placed on a platform surrounded by a motorized drum (20
rpm) lined with black and white stripes of defined spatial fre-
quencies on interchangeable inserts. Embryos were assessed for
1 min per trial, with trials consisting of assessment in both
clockwise and counterclockwise directions with inserts achieving
either 0.06 or 0.10 cycles per degree. Infrared monitoring and a
custom program written by Dr Frank Schaeffel (University of
Tübingen) were used to monitor and measure eye movement/
position.
Statistical analyses
For continuous variables, data are reported either as individual
values with the median and standard error of the mean (SEM)
indicated or as box and whisker plots indicating the interquar-
tile range (IQR) and median, minimum, and maximum values
of the range. Categorical variables are summarized as percen-
tages. Continuous variables were compared by Student’s t-test
(or Mann-Whitney U-test) or one-way ANOVA as applicable,
while the categorical variables are compared by Fisher’s exact
test. Statistical analyses were conducted using GraphPad Prism
6.00 (La Jolla, California, USA) and PARTEK Genomics Suite
(Partek Inc., St. Lois, MO, USA). The statistical level of signifi-
cance was set at P50.05.
Data availability
The data that support the findings of this study are available
from the corresponding authors, upon reasonable request, with
the exception of primary patient sequencing data, which cannot
be made available due to patient consent.
Results
Clinical phenotype and genetic
investigations
Affected individuals were born after uneventful pregnancies
and presented in most cases early in life with developmental
delay (Fig. 1, Table 1, Supplementary Figs 1–5 and
Supplementary Table 2). Various degrees of ataxia, hypo-
tonia, and dystonia were present in all affected individuals,
preventing independent ambulation. Likewise, nystagmus
was commonly described. In addition, all affected individu-
als displayed intellectual disability and speech delay. Two
siblings further presented with therapy-resistant epilepsy. No
major dysmorphic features were found. In two individuals,
retinal pigment alterations were noticed. Brain MRI revealed
mild cerebellar atrophy and vermian atrophy without other
major structural abnormalities in most affected individuals
while in one case (Subject 9) bilateral hyperintensities at the
nucleus caudatus area were noted (Fig. 1C and
Supplementary Fig. 5). No hearing or vision problems were
noted and in cases where nerve conduction studies were per-
formed, these were normal. Transmission electron micros-
copy (TEM) on peripheral blood lymphocytes from Subject
2 and lymphoblastoid cells from Subject 3 revealed more
multilayered vesicles compared to control cells
(Supplementary Fig. 6).
Exome sequencing did not identify variants in known dis-
ease genes but revealed homozygous missense variants in
VPS41 (GenBank: NM_014396) that fully segregated with
the phenotype in families where segregation analysis was
performed (Fig. 1A and Supplementary Figs 2–5). No other
likely pathogenic variants were identified. Other than
c.853T4C (p.Ser285Pro), which was found twice in a het-
erozygous state in gnomAD (minor allele frequency:
0.000007), the encountered variants [c.1898G4C
(p.Arg633Pro), c.2372G4T (p.Cys791Phe), and c.38A4G
(p.Glu13Gly)] have not previously been reported in publicly
available genome databases (Fig. 1D). All variants were fam-
ily-specific except for c.853T4C (p.Ser285Pro), which was
encountered in two different families from Saudi Arabia. All
missense variants occur in evolutionarily conserved amino
acid positions that in silico modelling suggests are likely to
disturb protein structure (Fig. 1D and E and Supplementary
Fig. 7A and B).
In silico analysis predicts reduced
VPS41 function in affected
individuals
Protein modelling showed that VPS41 contains an acidic
N-terminal extension (residues 1–29), a WD40 b-propeller
domain (residues 30–361), a central superhelical structure
composed of clathrin heavy-chain repeats (CHCR; residues
362–81) and a C-terminal RING (really interesting new
gene) zinc finger (787–852) (Fig. 1D and E). Glu13Gly
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attenuates the acidic charge of the N-terminal extension.
Glu-rich acidic regions are frequently used for protein local-
ization and ligand recognition (Uversky, 2013) and the mu-
tation might abrogate such functions. Ser285Pro affects the
WD40 domain. Ser285 is part of a buried b-strand and a
proline in this position would disrupt this secondary struc-
ture and decrease shape complementarity within the densely
packed protein core. Because of this disruptive effect on the
WD40 domain, Ser285Pro might affect ARL8B binding
(Khatter et al., 2015). The interaction of VPS41 with
ARL8B through its effector SKIP (SifA and kinesin-
interacting protein) contributes to lysosomal localization and
trafficking and degradation of EGFR (Khatter et al., 2015).
Interestingly, when Arl8b is silenced, lysosomal cargo deliv-
ery is impaired (Khatter et al., 2015). The Arg633Pro muta-
tion found within the CHCR distorts the a-helix because the
rigidity of proline and its inability to donate a hydrogen
bond lead to strong kinks in helices. Finally, residue 791
represents the first cysteine of the zinc finger/RING-type do-
main and its mutation to Phe is expected to abolish zinc
binding and would introduce steric clashes (Matthews and
Sunde, 2002). Thus, each of the identified variants is
Figure 1 Bi-allelic variants in VPS41 lead to a progressive developmental disorder with cerebellar dysfunction. (A) Pedigrees of
Families 1–5 with affected Subjects 1–9 (closed symbols), with carriers indicated by dots. (B) Frontal facial and full body photographs of Subjects
7 (female) and 8 (male) in a sitting position; both children were wheelchair-bound. Individuals present with hypotonic face, slightly low-set ears,
long eyelashes, full cheeks, small, open mouth with full lips. Full body images illustrate failure to thrive, marked hypotonia in Subject 8, spastic
thoracic deformity, and flexion contractures in the upper limbs of the Subject 7. (C) Brain MRI of affected Subjects 3, 5, 6 and 9, showing midline
vermian atrophy (Subject 3), mild cerebellar vermis hypoplasia/atrophy (Subject 5), milder (compared to the sibling Subject 5) cerebellar vermis
hypoplasia/atrophy (Subject 6) and no overt cerebellar volume reduction (first image) but bilateral hyperintensities in the nucleus caudatus area
(arrows, second image) (Subject 9). (D) Schematic overview of the VPS41 protein with identified variants indicated. (E) Structural protein model-
ling showing that VPS41 contains an acidic N-terminal extension (residues 1–29, red), a WD40 b-propeller domain (residues 30–361, white), a
central superhelix structure composed of clathrin heavy-chain repeats (CHCR; residues 362–781, grey) and a C-terminal RING zinc-finger (787–
852, black). The complete structure is shown in the centre as a ribbon drawing, with the mutated residues highlighted as coloured sphere models.
The insets show the structural context of each mutation, except for E13G, which is located in a flexible region. The other insets show the original
residue as a stick model, coloured as in the overview. The mutated residue is shown superimposed as a white stick model. Size and orientation
of the red discs show the extent and direction of steric clashes.
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predicted to affect protein domains implicated in mediating
ligand interactions, possibly leading to an impact on VPS41
function and stability. The level of weakening or disruption
of these interactions possibly explains the diverse patient
specific differences (Fig. 1E, Table 1 and Supplementary
Table 2).
VPS41 is moderately expressed in the cerebral cortex and
cerebellum (Supplementary Fig. 8A), but is expressed highly
in Purkinje cells (Supplementary Fig. 8B). Since co-expressed
genes are considered more likely to be functionally related
and may provide clues about gene function and regulation
(Stuart et al., 2003; van Dam et al., 2015), we searched for
genes that are co-regulated with VPS41 in over 4000 human
RNASeq data (van Dam et al., 2015; Al-Harazi et al.,
2019). We identified 105 genes (correlation coefficient 5
0.4), of which almost 80%, like VPS41, are expressed in the
nervous system (Supplementary Table 3). Functional enrich-
ment and pathway analyses of VPS41 co-expressed genes
revealed significant enrichment for terms associated with
nervous system development and function, vesicle-mediated
transport, cellular component organization, phagosome mat-
uration and autophagy pathways (VPS39, VPS41 and
PIK3C3) (all P-values 5 0.01) (Supplementary Fig. 9 and
Supplementary Tables 4–6).
VPS41 variants show functional
defects in human embryonic stem
cells
To functionally test VPS41 variants in a cellular model, we
generated human ESCs knock-out (KO) for VPS41 by
CRISPR-Cas9 engineering (Barakat et al., 2018; Perenthaler
et al., 2020). A clone was obtained harbouring a homozy-
gous 1 bp insertion (chr7:38908803_38908804insT), lead-
ing to a frameshift and premature stop codon
(c.110_111insA, N37Kfs*5), resulting in the full absence of
all VPS41 as assessed by immunoblotting (Supplementary
Fig. 10A–C). VPS41 KO did not alter ESC growth charac-
teristics but resulted in minor flattened morphology com-
pared to parental wild-type ESCs (Supplementary Fig. 10D).
Previous work showed that the transcription factor TFE3
can be cytoplasmic or nuclear, depending on its phosphoryl-
ation state, and that this is regulated by mTORC1 signalling
and lysosomes (Yang et al., 2018; Shin and Zoncu, 2020).
In agreement with lysosomal dysfunction (Villegas et al.,
2019), the absence of VPS41 resulted in solely nuclear TFE3
localization (Fig. 2A). VPS41 KO cells showed upregulation
of the lysosomal protein LAMP2 (Fig. 2C, D and
Supplementary Fig. 10E), likely due to nuclear TFE3 local-
ization (Fan et al., 2018). Thus, the absence of VPS41 pro-
vided two clear phenotypical differences between wild-type
and VPS41 KO ESCs and we used the cellular phenotype of
this VPS41 KO background to assess the functionality of
wild-type and mutant VPS41 proteins in rescue experiments.
We used the expression of V5-VPS41-T2A-GFP fusions,
allowing the tracking of transfected cells at the population
and single cell level. Fluorescence-activated cell sorting
(FACS) analysis 48 h after transient transfection showed a
significant reduction in the percentage (Fig. 2E) and intensity
(Supplementary Fig. 10F) of GFP + cells for the Arg633Pro
and Cys791Phe variants, whereas transfection efficiency for
a spiked-in mCherry control was similar amongst all trans-
fections (Supplementary Fig. 10G). In agreement, immuno-
blotting confirmed reduced protein expression of these both
mutants, as well as a slightly reduced expression of
Ser285Pro (Fig. 2C and D). This indicates that the variants
encountered result in reduced RNA or protein expression and
possibly stability. Whereas transfection of wild-type VPS41
resulted in downregulation of LAMP2 in transfected KO
ESCs, expression of Ser285Pro, Cys791Phe, and to a lesser
extent Arg633Pro, failed to downregulate LAMP2 at a popu-
lation level (Fig. 2D). We then moved to single cells and eval-
uated the cellular distribution of TFE3. Upon transient
transfection of wild-type VPS41, cytoplasmic localization of
TFE3 was restored in GFP + cells (Fig. 2A and B). In contrast,
transient transfection of Glu13Gly resulted in a significantly
reduced rescue of the TFE3 cytoplasmic localization in GFP +
cells, indicating a reduced functionality of this mutant despite
normal protein expression (Fig. 2A and B). TFE3 relocaliza-
tion was similar for Ser285Pro, Arg633Pro, and Cys791Phe
in GFP + cells, indicating that if sufficient overexpression can
be achieved, these mutants can promote TFE3 relocalization.
Together, these data further support our in silico analysis,
providing functional evidence that the encountered variants
affect VPS41 protein expression levels and result in measur-
ably reduced VPS41 function in human cells.
Zebrafish disease modelling
recapitulates key clinical findings
To investigate the neurological effects of VPS41 loss in vivo,
we mutated the single vps41 homologue in zebrafish, which
shares 82% amino acid identity with the human protein, by
injection of CRISPR/Cas9 and gRNA ribonucleoprotein
complexes into oocytes (Supplementary Fig. 11). CRISPR-
mediated mutants (crispants) generated in this way have
been shown to exhibit highly efficient mutagenesis, often
achieving complete loss of the wild-type target sequence, and
can reliably phenocopy existing loss-of-function mutants and
thus facilitate rapid and reliable investigations in F0 embryos
(Shah et al., 2015; Kuil et al., 2019). Zebrafish vps41 crisp-
ants, having a vps41 disruption efficiency between 60 and
90%, had normal general morphology in the first 3 days but
displayed a severe lack of pigmented melanocytes when
compared to control gRNA-injected oocytes (Fig. 3A).
Pigmentation defects were partially corrected by injection of
wild-type vps41 mRNA at the 1–2-cell stage (Supplementary
Fig. 11). After 5 days, 100% of vps41 crispants showed a
lack of swim bladder inflation—ultimately resulting in a loss
of viability—as well as decreased body length and reduced
pigmentation both throughout the body and in the retina
(Fig. 3A–C). These specific pigmentation phenotypes are
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consistent with observations of loss-of-function of other
HOPS components vps33a/Vps33a in mice and vps11,
vps18 and vps39 in zebrafish (Thomas et al., 2011; Zhen
and Li, 2015; Berg et al., 2016), while swim bladder defects
were also noted in all three zebrafish mutants. Deficiencies
in surfactant production or distribution during swim bladder
development are believed to contribute to an inability to
properly inflate (Chen et al., 2018). Together, these data
Figure 2 VPS41 variants contribute to impaired lysosomal functions in vitro. (A) Immunocytochemistry assessing TFE3 in rescue
experiments using transient expression of wild-type (WT) and mutant VPS41-t2a-GFP in VPS41 KO ESC. Transfected cells are marked by GFP
and GFP + cells showing no TFE3 relocalization to the cytoplasm are marked with white asterisks. Nuclei are counterstained with DAPI. Scale
bars = 50 mm. (B) Quantification of A counting a minimum of 80 GFP + cells from three replicates. ***P = 0.0001, binomial test (expected distri-
bution based on relocalization upon transfection with the wild-type construct). (C) Western blotting detecting VPS41 (endogenous VPS41
99 kDa, V5-tag-VPS41 105 kDa, input 30 mg) and LAMP2 (100–120 kDa, input 20 mg), in wild-type and VPS41 KO ESCs and VPS41 KO ESCs tran-
siently rescued with wild-type or mutant VPS41. (D) Quantification of C, *P5 0.05; **P5 0.01; ***P5 0.001 one-way ANOVA, multiple com-
parison test of mutant constructs to the wild-type. (E) Percentage of GFP + cells upon transient transfections of VPS41-KO cells with VPS41-
GFP plasmid spiked with mCherry, expressing wild-type or mutant VPS41. ***P = 0.0006, ****P5 0.0001, one-way ANOVA, multiple comparison
test of mutant constructs to the wild-type; 417 000 cells were analysed per sample.
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Figure 3 VPS41 disease modelling in zebrafish recapitulates lysosomal abnormalities and indicates microglial and cerebellar
dysfunction. (A) Gross morphology of vps41 crispant versus control embryos at 5 dpf. Magnified views of the skin and eyes show abnormal
melanocyte morphology and reduced pigmentation in both the skin melanocytes and retinal pigment epithelium. (B) Measurements of body
length at 3 and 5 dpf, suggesting a reduced growth rate in vps41 crispants versus controls (n = 15 each). (C) At 5 dpf, swim bladders were not vis-
ible in any of the vps41 crispant embryos, while being fully developed by this time in the majority of controls (n = 50). (D) Schematic of the OKR
experiment, indicating the eye angles measured. (E) Representative OKR traces for vps41 crispant and control embryos under four different con-
ditions. (F) Quantification of saccades produced in response to visual stimuli (n = 6 for each condition). (G) Average saccade amplitude per trial,
taken from left eye traces (n = 6 for each condition). (H) LysoTrackerTM staining of 3 dpf embryos, revealing increased acidification of vps41 crisp-
ant brains that is largely concentrated within Mpeg1 + cell (microglia) compartments. Scale bars = 20 mm. (I) Quantification of acidic compart-
ments within microglia in the brain at 3 dpf (6–8 cells counted per embryo, n = 4 embryos each). (J) Compared to control injected embryos at 5
dpf, vps41 crispants show a remarkably increased level of acidity across the entire brain, detected using LysoTrackerTM, that is significantly
reduced when embryos are additionally injected with wild-type vps41 mRNA at the 1–2 cell stage. (K) Quantification of the LysoTrackerTM signal
intensity across the whole brain of 5 dpf control, vps41 and vps41 + mRNA-injected embryos (n = 5 controls, n = 9 vps41, and n = 7
vps41 + mRNA). Data-points in B, F, G and I are individual measurements (circles) and mean (bars) and error bars indicate SEM. CW = clock-
wise; CCW = counterclockwise; cpd = cycles per degree; dpf = days post-fertilization. *P5 0.05; **P5 0.01; ***P5 0.001; ****P5 0.0001.
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further support a role for Vps41 and the HOPS complex in
the development and function of LROs, including both mel-
anosomes (the pigment-producing organelles within melano-
cytes and the retinal pigment epithelium) and the surfactant-
producing organelles involved in the teleost surfactant pro-
duction system (Chen et al., 2018; Delevoye et al., 2019).
Abnormal eye movements are associated with cerebellar
injury and can be diagnostic of ataxia (Cogan et al., 1982).
Thus, we analysed the optokinetic response (OKR) of
vps41-mutated zebrafish larvae, using a well-established
zebrafish assay for cerebellar dysfunction (Namikawa et al.,
2019). In contrast to control injected larvae, which demon-
strated normal responses to visual stimuli, vps41 crispants
showed a dramatically reduced response and, when present,
saccades had both reduced amplitude and frequency
(Fig. 3D–G), indicating defects in eye movement control and
suggesting cerebellar dysfunction. Spontaneous eye move-
ments in the absence of stimulation were observed, removing
the possibility that crispants were simply unable to move
their eyes. The underlying mechanisms of reduced visual per-
formance seen in vps41 crispants remain unclear.
Nevertheless, data from both vps11 and vps39 mutant
zebrafish indicate that ineffective digestion of material phag-
ocytosed by the retinal pigment epithelium could contribute
by hindering proper development and function of photo-
receptor cells, further pointing to a defect in LRO function
(Schonthaler et al., 2007; Thomas et al., 2011).
While no differences were seen in the gross morphology or
size of vps41 crispant brains (Supplementary Fig. 11C), we
sought to further investigate potential underlying neurologic-
al abnormalities that could help understand the progressive
neurodevelopmental phenotypes seen in human disease.
During early neurodevelopment microglia are highly endo-
cytic and phagocytic, functions that rely heavily on efficient
membrane trafficking and LRO function, the dysfunction of
which is readily observed in zebrafish larvae (Berg et al.,
2016; Kuil et al., 2019). Early defects in microglial function
have been linked to a wide range of neurological diseases,
including lysosomal storage diseases, where lysosomal dys-
function in microglia has been implicated as a primary
driver (Kuil et al., 2019). Thus, to assess whether microglial
dysfunction may play a role in VPS41 variant-driven path-
ology, we used neutral red staining to observe microglia dur-
ing development of vps41 crispants and control larvae
(Supplementary Fig. 11B). This revealed that vps41-deficient
microglia have distinct morphological abnormalities suggest-
ive of larger, or possibly more numerous, lysosomal com-
partments compared to microglia from control larvae. To
more carefully dissect this phenotype, we sought to visualize
lysosomes in vivo in the developing brain using
LysoTrackerTM in zebrafish where microglia were transgeni-
cally tagged with green fluorescent protein (GFP). Confocal
imaging revealed that vps41 deficiency resulted in a dramatic
increase in LysoTrackerTM signal throughout the entire
brain, in addition to highly amoeboid, swollen microglia
with large, supernumerary acidic compartments in contrast
to those in control injected zebrafish (Fig. 3H and I).
Importantly, LysoTrackerTM signal in the brain was signifi-
cantly abrogated by the injection of wild-type zebrafish
vps41 mRNA into crispant oocytes at the 1–2-cell stage
(Fig. 3J and K), again supporting the specificity of our obser-
vations and utility of this model for the study of vps41 func-
tion. Together, these data further support a role for
lysosomal dysfunction upon vps41 disruption and, in paral-
lel with observations of macrophage defects seen in vps39
mutant zebrafish (Schonthaler et al., 2007), suggest disrup-
tion of microglial function. However, while the largest
LysoTracker + compartments both in crispants and controls
appeared within mpeg + cells, it is important to note that a
substantial increase in LysoTracker + compartments inside
cells other than microglia was also observed only in vps41
crispants. This supports a more global LRO defect that like-
ly impacts neural progenitors as well, contributing to devel-
opmentally seeded neurological defects that are likely further
compounded by microglial dysfunction.
Discussion
Here we establish that VPS41 bi-allelic mutations cause cere-
bellar ataxia. As the identified variants fail to completely res-
cue the lysosomal dysfunction seen in VPS41 KO ESCs, and
VPS41 deficiency causes lysosomal abnormalities in multiple
brain cell types in the developing zebrafish brain, it is possible
that membrane trafficking defects in neurons underlie cerebel-
lar atrophy. Additionally, gene network analysis suggests that
VPS41 dysfunction may disrupt a number of signalling path-
ways linked to neuronal development and maintenance of
brain function (Supplementary Fig. 9 and Supplementary
Tables 4–6). Nearly all spinocerebellar ataxias have been
characterized by Purkinje cell deterioration and cerebellar at-
rophy (Huang and Verbeek, 2018). A scenario of reduced
viability of Purkinje cells is also plausible for VPS41-related
ataxia and may help explain cerebellar atrophy. Although we
did not detect clear differences directly in zebrafish Purkinje
cells during the early development of vps41 crispants
(Supplementary Fig. 11D), cellular dysfunction is supported
by our OKR results and may precede visible deterioration.
However, we did observe distinct lysosomal accumulation
and abnormalities at a very early stage in microglia. As lyso-
somal accumulation in microglia inhibits their function and
thus is detrimental to brain development and function, com-
bined with the understanding that a loss of microglia has
been shown to cause a spectrum of brain abnormalities,
including cerebellar hypoplasia (Oosterhof et al., 2019; Burns
et al., 2020), further investigation of the role of microglia in
the disease pathogenesis is warranted.
It is interesting to note the overlap of some phenotypes
observed in models of VPS loss-of-function, yet ours is the
first report to explicitly link variants in a HOPS-specific VPS
gene to human brain disease. Intriguingly, many of the exist-
ing Vps/vps mutant animal models were identified in genetic
screens for pigmentation defects and have been proposed to
model Hermansky-Pudlak syndrome (HPS), a disorder
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typified by albinism and bleeding, but typically no neuro-
logical abnormalities. Mutations associated with HPS include
mutations in genes involved in LRO biogenesis, though to
date no VPS mutations have been linked to this disease in
humans (Merideth et al., 2020). This suggests that while
LRO dysfunction contributes to familiar phenotypes across a
spectrum of human diseases, VPS (and specifically HOPS)
mutations diverge from other LRO-associated diseases as
they appear to more prominently affect the nervous system.
VPS mutant animal models may therefore require reassess-
ment and possible reclassification as models of cerebellar
dysfunction.
Together, our work provides evidence that genetic defects
in VPS41, and thus the HOPS complex, result in dysregu-
lated neurodevelopment in vertebrates, with a predominant
ataxia phenotype, driven at least partially through LRO
abnormalities. We suggest that screening for VPS41 variants,
and perhaps other HOPS members, should therefore be con-
sidered among cases of unsolved autosomal recessive ataxia.
Our work adds to the increasing knowledge on autosomal
recessive cerebellar ataxias by providing evidence that genet-
ic defects in the HOPS-specific subunit VPS41 lead to abnor-
malities in lysosome-related organelles in multiple cell types,
including microglia. This contributes to disturbed neurode-
velopment and ataxia, though further studies are needed to
clearly dissect the underlying mechanisms of these
connections.
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